Young adults with cystic fibrosis with low microbiome diversity in their sputum have a greater risk of early end-stage lung disease, a novel study finds. According to the researchers from the Canada their findings could be used to identify patients with CF at increased risk of disease progression for more intensive monitoring and treatment. In ...
Could lower airway microbiota serve as a biomarker for CF progression?
By Nicola Garrett
4 Sep 2018